Literature DB >> 3090135

Experimental esophagitis in a rabbit model. Clinical relevance.

L F Johnson, J W Harmon.   

Abstract

Esophagitis occurs in patients with excessive acid and/or alkaline gastroesophageal reflux. This observation prompted us to develop a continuously perfused in vivo rabbit esophageal model to examine the potential for different endogenous injurious agents to cause H+ back diffusion and morphologic evidence of esophagitis. We found that HCl at physiologic pH values did not break the mucosal barrier to H+ back diffusion or cause esophagitis. Bile salts at physiologic concentrations in both an acid or alkaline perfusate broke the mucosal barrier and caused H+ back diffusion, but failed to cause a morphologic injury consistent with clinical reflux esophagitis. Instead, proteolytic enzymes, such as pepsin in an acid environment and trypsin in an alkaline environment, caused a severe hemorrhagic erosive esophagitis consistent with that seen clinically. We feel new therapeutic strategies for the treatment of reflux esophagitis should be directed at proteolytic enzymes rather than only HCl or bile salts. Finally, we showed sucralfate to be a mucosal protectant against the acid-pepsin injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090135     DOI: 10.1097/00004836-198606001-00006

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  12 in total

1.  Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux.

Authors:  S Mattioli; V Pilotti; M Spangaro; W F Grigioni; R Zannoli; V Felice; A Conci; G Gozzetti
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

2.  Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.

Authors:  M J Collen; R M Strong
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

3.  Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux.

Authors:  H J Stein; A P Barlow; T R DeMeester; R A Hinder
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

Review 4.  Reflux events and sleep: are we vulnerable?

Authors:  William C Orr
Journal:  Curr Gastroenterol Rep       Date:  2006-06

5.  Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats.

Authors:  Yuji Naito; Kazuhiko Uchiyama; Masaaki Kuroda; Tomohisa Takagi; Satoshi Kokura; Norimasa Yoshida; Hiroshi Ichikawa; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

6.  Variability in the composition of physiologic duodenogastric reflux.

Authors:  K H Fuchs; J Maroske; M Fein; H Tigges; M P Ritter; J Heimbucher; A Thiede
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

7.  Duodenogastric reflux in patients with Barrett's esophagus.

Authors:  J P Waring; J Legrand; A Chinichian; R A Sanowski
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

8.  pH-metric analysis after successful antireflux surgery: comparison of 24-hour pH profiles in patients undergoing floppy fundoplication or Roux-en-Y duodenal diversion.

Authors:  J T Salminen; J A Salo; J A Tuominen; O J Rämö; M Färkkilä; S P Mattila
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

9.  Direct measurement of acid permeation into rat oesophagus.

Authors:  S Tanaka; S Chu; M Hirokawa; M H Montrose; J D Kaunitz
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

10.  A weakly acidic solution containing deoxycholic acid induces esophageal epithelial apoptosis and impairs integrity in an in vivo perfusion rabbit model.

Authors:  Nicolas A Pardon; Maria Vicario; Hanne Vanheel; Tim Vanuytsel; Laurens J Ceulemans; Michael Vieth; Marcel Jimenez; Jan Tack; Ricard Farré
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-21       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.